Literature DB >> 33644506

Vital Role of Transesophageal Echocardiographic Surveillance of a Left Atrial Appendage Perforation Complicating Attempted Percutaneous Appendage Occlusion.

Edan Zitelny1, Ryan Brunetti1, Matthew Singleton1, Elijah Beaty1, Karl Richardson1.   

Abstract

Entities:  

Keywords:  Atrial fibrillation; Cardiac tamponade; Complication; Pericardial effusion; Watchman

Year:  2020        PMID: 33644506      PMCID: PMC7887453          DOI: 10.1016/j.case.2020.09.007

Source DB:  PubMed          Journal:  CASE (Phila)        ISSN: 2468-6441


× No keyword cloud information.

Introduction

In patients with atrial fibrillation (AF) unable to tolerate systemic anticoagulation, left atrial appendage (LAA) occlusion is one potential alternative strategy for stroke risk reduction. The Watchman device (Boston Scientific, Marlborough, MA) is one such LAA occlusion device demonstrating a stroke risk reduction comparable with long-term anticoagulation., The procedure, however, is not without risk, as cardiac perforation is a rare but potentially lethal complication that can occur during device implantation, occasionally leading to pericardial tamponade., In a recent post–US Food and Drug Administration approval experience study, 1.31% of patients developed pericardial effusion, and 1.02% of these patients ultimately required pericardiocentesis or surgery., Given this concern and the need for accurate LAA sizing and device guidance during implantation, procedural transesophageal echocardiographic (TEE) imaging has been a mainstay of implantation. Concurrently, the alternative use of intracardiac echocardiography and the ability to avoid general anesthesia has raised the question of the net benefit of both procedural TEE imaging and the additional attending imager during implantation. We present a case in which skilled TEE imaging was a vital procedural addition enabling the quick visualization, evaluation, and active monitoring of a potentially severe complication of Watchman implantation.

Case Presentation

An 82-year-old man with a history of permanent AF on warfarin, hypertension, coronary artery disease, heart failure with reduced ejection fraction, prior ischemic stroke without residual neurologic deficits, and type 2 diabetes mellitus presented for LAA occlusion with the Watchman device. The patient's calculated HAS-BLED score of 4 (suggesting an 8.9% annual bleeding risk) and prior life-threatening diverticular bleed prompted consideration of alternatives to systemic anticoagulation. In the setting of a CHA2DS2-VASc score of 8, yielding an annual stroke risk potentially >10%, the patient and physician reached a shared decision to proceed with LAA occlusion. Preprocedural TEE imaging demonstrated no LAA thrombus and a relatively shallow appendage with a superiorly directed chicken wing. LAA measurements (width × depth) at 0°, 45°, 90°, and 135° were 20.0 × 21.4 mm, 19.2 × 21.7 mm, 18.5 × 23.0 mm, and 20.4 × 24.0 mm, respectively. Right femoral venous and transseptal access in addition to delivery sheath placement within the LAA were uneventful (Figure 1, Video 1). A 27-mm Watchman device was selected with a plan to use some of the superior chicken wing for added depth.
Figure 1

Midesophageal TEE image of guiding catheter in the LAA, which has a chicken-wing morphology. LA, Left atrium.

Midesophageal TEE image of guiding catheter in the LAA, which has a chicken-wing morphology. LA, Left atrium. After three failed attempts to seat the device in the LAA, because of the feet of the device slipping inferiorly and the shoulder of the device falling into the distal chicken wing (Figure 2, Video 2), the procedure was aborted. Efforts included two partial recaptures and two device exchanges of a 27-mm and a 24-mm device, respectively. Following the third attempt, the interval development of a circumferential mild to moderate pericardial effusion was noted on TEE imaging (Figure 3, Video 3). The patient's systolic blood pressure subsequently decreased by approximately 30 mm Hg, raising concerns for progressive cardiac tamponade. Close inspection of the LAA with color Doppler revealed active LAA-pericardial flow suggesting LAA perforation with hemopericardium (Figure 4, Videos 4 and 5). Cardiothoracic surgery was notified, and a pericardial drain was quickly placed, yielding approximately 300 mL of bloody fluid. In the interim, further investigation with TEE imaging allowed the proceduralist to monitor flow from the LAA to the pericardium, which slowly decreased over 30 min. The size of the effusion, extent of perforation flow, and development of pericardial thrombus were monitored in real time (Figure 5, Videos 6 and 7) as treatments were administered to achieve hemostasis. Ultimately, 1 U of fresh-frozen plasma, 100 mL of protamine, and the application of negative pressure via the pericardial drain were required. Although 1,415 mL of bloody fluid was removed from the patient's pericardium, the patient's blood pressure remained stable. In this case, procedural TEE imaging and skilled imaging helped avoid major surgical intervention given the ability to visualize and monitor the resolution of the LAA perforation. At the conclusion of the procedure, there was a trivial to small, stable pericardial effusion, LAA-to-pericardial flow had ceased, and a thrombus was visualized in the pericardial space at the site of the perforation (Figure 6, Videos 8 and 9).
Figure 2

Midesophageal TEE image of the Watchman device malpositioned and incompletely expanded upon attempted deployment in the LAA. LA, Left atrium.

Figure 3

Midesophageal TEE image of the developing pericardial effusion (red arrow) noted following the third attempt of Watchman device placement. LA, Left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle.

Figure 4

TEE images of LAA perforation visualized by color Doppler flow from the LAA into the pericardial space (red arrows), seen in two midesophageal imaging planes, 129° and 68°. LV, Left ventricle.

Figure 5

Midesophageal TEE images of LAA perforation resolving, evidenced by decreased flow on color Doppler (red arrow) as well as the presence of a small thrombus (orange arrow) visualized at site of perforation.

Figure 6

Midesophageal TEE color Doppler images demonstrating the cessation of flow through the LAA perforation as well as the presence of thrombus (red arrow) in the pericardial space.

Midesophageal TEE image of the Watchman device malpositioned and incompletely expanded upon attempted deployment in the LAA. LA, Left atrium. Midesophageal TEE image of the developing pericardial effusion (red arrow) noted following the third attempt of Watchman device placement. LA, Left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle. TEE images of LAA perforation visualized by color Doppler flow from the LAA into the pericardial space (red arrows), seen in two midesophageal imaging planes, 129° and 68°. LV, Left ventricle. Midesophageal TEE images of LAA perforation resolving, evidenced by decreased flow on color Doppler (red arrow) as well as the presence of a small thrombus (orange arrow) visualized at site of perforation. Midesophageal TEE color Doppler images demonstrating the cessation of flow through the LAA perforation as well as the presence of thrombus (red arrow) in the pericardial space. The patient was admitted to the cardiovascular intensive care unit for overnight monitoring. Serial transthoracic echocardiography performed to monitor for recurrence of hemopericardium demonstrated continued stability of the effusion. The pericardial drain was removed on postprocedural day 2 without recurrence of the effusion, and the patient was safely discharged on postprocedural day 3.

Discussion

Echocardiography is critical in the both the planning and safe execution of complex intracardiac procedures. Our case highlights this fact while providing a valuable example of TEE findings during a procedural complication. Intraoperative TEE imaging was crucial to confirming the diagnosis of the LAA perforation and safely monitoring the perforation while the patient received definitive and, fortunately, nonsurgical treatment for pericardial tamponade. Several cohort studies have investigated the efficacy, safety, and complications related to the use of the Watchman device. In the first half of the PROTECT-AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial, the complication rate was nearing 10%. However, postmarket surveillance has demonstrated that the rate lies closer to 4%, with a 95% successful placement rate. This rate of complications is similar to the rate of complications during AF ablation procedures. Although the incidence of complications from the Watchman procedure is relatively low, the consequences of these complications pose potentially severe risks to patients. There are several case reports describing the use of intraoperative TEE imaging to identify a pericardial effusion and signs of tamponade. Other reports have described the use of fluoroscopy to visualize contrast transit from cardiac chambers to the pericardium through a perforation.8, 9, 10 However, to our knowledge, this report is the first to publish images of color Doppler identification and surveillance to resolution of active LAA-to-pericardial flow. This case highlights the importance of continuous intraoperative TEE imaging and the presence of a skilled imager as a standard of care with placement of these devices., TEE imaging was able to quickly diagnose the pericardial effusion, prompting the concern for perforation when the patient's blood pressure started to drop. Although cardiac surgery was notified, surgical intervention was fortunately avoided because of the swift action of the proceduralist and the team's confidence in the ability to visualize the perforation resolving with time. Had continuous, active TEE monitoring not been in place for this patient, there is a significant likelihood that he may have required emergent cardiac surgical intervention, including a possible midline sternotomy. In a prior published case with a more severe LAA perforation, TEE imaging was crucial in preventing significant morbidity and mortality as well. In this case, gross LAA perforation with the catheter in the transverse pericardial sinus was visualized on TEE imaging following attempted deployment of a Watchman device. However, the authors' primary focus in that case was the management of the perforation by subsequently deploying the Watchman device into the perforation, controlling the expanding pericardial effusion. In our case, placement was not an option in this acute situation due to the challenging anatomy of the LAA, and the perforation was small enough to allow the possibility of transesophageal echocardiography–guided minimally invasive management. In our experience, TEE imaging was able to both localize and evaluate the severity of the LAA perforation. Furthermore, after reversal of anticoagulation, TEE imaging also monitored the resolution of the effusion and demonstrated slowing and ultimate cessation of LAA-to-pericardial flow, thus reassuring the care team of likely patient stability. The use of TEE imaging in this case was vital to ensuring this patient's excellent outcome after a procedural complication. The detailed images and video obtained during this case may serve as an example of how to identify, monitor, and treat this relatively rare complication of an increasingly common procedure.

Conclusion

This report describes the use of procedural TEE imaging to identify and monitor the treatment of LAA perforation complicating attempted LAA occlusion. Imaging of the leak itself enabled real-time monitoring that assisted in titration of therapies and helped avoid escalation to more aggressive surgical intervention, highlighting the importance of skilled TEE imaging. This case offers a valuable example of the utility of procedural TEE imaging and the value of color Doppler surveillance of LAA perforation.
  11 in total

1.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

Authors:  Vivek Y Reddy; Horst Sievert; Jonathan Halperin; Shephal K Doshi; Maurice Buchbinder; Petr Neuzil; Kenneth Huber; Brian Whisenant; Saibal Kar; Vijay Swarup; Nicole Gordon; David Holmes
Journal:  JAMA       Date:  2014-11-19       Impact factor: 56.272

2.  Left atrial appendage obliteration: mechanisms of healing and intracardiac integration.

Authors:  Robert S Schwartz; David R Holmes; Robert A Van Tassel; Robert Hauser; Timothy D Henry; Michael Mooney; Ray Matthews; Shephal Doshi; Russell M Jones; Renu Virmani
Journal:  JACC Cardiovasc Interv       Date:  2010-08       Impact factor: 11.195

3.  Percutaneous management of periprocedural cardiac perforation during left atrial appendage closure.

Authors:  Nico Reinsch; Hagen Kälsch; Philipp Kahlert
Journal:  Clin Res Cardiol       Date:  2015-11-26       Impact factor: 5.460

4.  Pulmonary artery perforation caused by a left atrial appendage closure device.

Authors:  Cong Lu; Jie Zeng; Qingguo Meng; Zhi Zeng
Journal:  Catheter Cardiovasc Interv       Date:  2019-10-17       Impact factor: 2.692

5.  Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.

Authors:  Vivek Y Reddy; Douglas N Gibson; Saibal Kar; William O'Neill; Shephal K Doshi; Rodney P Horton; Maurice Buchbinder; Nicole T Gordon; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2016-11-02       Impact factor: 24.094

6.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

7.  Left Atrial Appendage Occlusion Complicated by Appendage Perforation Rescued by Device Deployment.

Authors:  Anna Sarcon; Dipayon Roy; David Laughrun; Mary Huntsinger; Jacqueline Schwartz; Jina Sohn; Rahul N Doshi
Journal:  J Investig Med High Impact Case Rep       Date:  2018-09-11

8.  CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome.

Authors:  Jesper Hastrup Svendsen; Jens Cosedis Nielsen; Stine Darkner; Gunnar Vagn Hagemann Jensen; Leif Spange Mortensen; Henning Rud Andersen
Journal:  Heart       Date:  2013-03-28       Impact factor: 5.994

9.  Role of transesophageal echocardiography during left atrial appendage occlusion device closure in a patient with non-valvular atrial fibrillation and angiodysplasia of the colon.

Authors:  Dinesh Kumar; Sunil Kumar; Nagraj Desai
Journal:  Ann Card Anaesth       Date:  2018 Jan-Mar

10.  Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014.

Authors:  Gerhard Steinbeck; Moritz F Sinner; Manuel Lutz; Martina Müller-Nurasyid; Stefan Kääb; Holger Reinecke
Journal:  Eur Heart J       Date:  2018-12-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.